Malaria vaccine trial offers hope - RTE.ie

A new malaria vaccine gave 100% protection from the disease to a group of participants in a clinical trial, scientists have said. Some 67 healthy volunteers who had never had malaria before were given different doses of the drug, called Sanaria PfsPZ-CVac.

New malaria vaccine effective in clinical trial - EurekAlert (press release)

IMAGE: The World Health Organization reports that some 214 million people became infected with malaria in the year 2015 alone. view more. Credit: University of Tuebingen. University of Tübingen researchers in collaboration with the biotech company ...

Sanaria's PfSPZ-CVac Vaccine Achieves High Level Protection Against Malaria in Clinical Trial - PR Newswire (press release)

BETHESDA, Md., Feb. 15, 2017 /PRNewswire/ -- In a report published today in Nature, (Sterile protection against human malaria by chemoattenuated PfSPZ vaccine) investigators from the University of Tübingen reported all nine subjects (100%) immunized ...

New malaria vaccine provides up to 100% immunity - domain-B

A malaria vaccine that mimics a mosquito bite has yielded encouraging results in human trials, its makers said on Thursday, raising hopes for thwarting a parasite that kills a child every two minutes. The candidate drug, called PfSPZ, provided up to ...

Experimental Vaccines Offer Promise in War on Malaria - Voice of America

FILE - Two children stricken with malaria rest at the local hospital in the small village of Walikale, Congo. Share. Share on Facebook · Share on Twitter · Share on Google+ · Email to a Friend. Print. See comments. WASHINGTON —. Two vaccine candidates ...

Malaria vaccine one step closer - Radio New Zealand

A vaccine for malaria has just passed its first clinical trial with human volunteers, giving them 100 percent immunity to the parasite that causes the disease. no capiton. A malaria vaccine is being developed in Germany Photo: AFP. Malaria kills ...

A New Malaria Vaccine Was 100% Effective in Clinical Trials - Futurism

The PfSPZ malaria vaccine was 100% effective in U.S. clinical trials and 48% effective in trials run in Mali, exhibiting a previously unseen level of sustained efficacy in that region. PfSPZ is just one of several promising malaria vaccines in ...

A Malaria Vaccine Passes A Major Trial With Ease - UPROXX

Malaria is a global medical nightmare. The parasitic infection, spread by mosquitoes, threatens half the world's population and killed 627,000 people in 2012 alone. As it's a protozoa, not a virus, a vaccine has been little more than a dream. Until now ...

Investigational PfSPZ malaria vaccine demonstrates considerable protection in Malian adults for duration of malaria ... - National Institutes of Health (press release)

An investigational malaria vaccine given intravenously was well-tolerated and protected a significant proportion of healthy adults against infection with Plasmodium falciparum malaria — the deadliest form of the disease — for the duration of the ...